Bauman JE, Saba NF, Roe D, Bauman JR, et al. Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer. J Clin Oncol 2023 Mar 28:JCO2201994. doi: 10.1200/JCO.22.01994.
PMID: 36977289